Recombinant Human Antithrombin (rhAT)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Human Antithrombin (rhAT), covering 2012-05-11 to 2012-05-11. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery [Phase 3]